Pantoprazole: Clinical Trials

183 trials of Pantoprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

126 completed, 19 unknown, 13 terminated, 11 recruiting. 48 Phase 4, 42 Phase 1, 37 Phase 3, 33 Not applicable, 19 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 448Completed 28, Terminated 6, Withdrawn 6, Unknown 5, Recruiting 2, Not yet recruiting 1
Phase 142Completed 37, Recruiting 3, Not yet recruiting 1, Withdrawn 1
Phase 337Completed 25, Unknown 5, Recruiting 2, Terminated 2, Withdrawn 2, Not yet recruiting 1
Not applicable33Completed 20, Unknown 6, Terminated 4, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 219Completed 11, Recruiting 5, Unknown 2, Terminated 1

Follow Pantoprazole: new trials by email Literature Review of Pantoprazole trials Research Report on Pantoprazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week
Cyanocobalamin 1000 Mcg Oral Tablet, Cyanocobalamin 1000 Mcg Sublingual Tablet, Proton Pump Inhibitor therapy only - Hypovitaminosis b 12
Phase 3Not yet recruitingTanta University232026-12-302025-05-13
A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants
CHF10196, Pantoprazole - Healthy Volunteers
Phase 1Not yet recruitingChiesi Farmaceutici S.p.A.182026-10-142026-07-06
Keverprazan vs Pantoprazole for the Treatment of ANVUGIB
Pantoprazole, Keverprazan - Non-variceal Upper Gastrointestinal Bleeding
Not applicableNot yet recruitingGeneral Hospital of Shenyang Military Region9082026-10-012026-08-20
A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants
Navlimetostat, Itraconazole, Rifampin - Healthy Female Adults
Phase 1RecruitingBristol-Myers Squibb802026-08-312026-10-05
Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors
Pantoprazole, olanzapine, Dexamethasone - Olanzapine, Breast Cancer
Not applicableRecruitingAlexandria University902026-05-102026-08-04
Pantoprazole After Prophylactic Endoscopic Variceal Treatment
Pantoprazole - Esophageal and Gastric Varices, Liver Cirrhosis
Not applicableEnrolling by invitationGeneral Hospital of Shenyang Military Region2082026-03-272026-04-01
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)
Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days, Pepcid (Famotidine) 20 mg q 12 hrs for 3 days - Acute Kidney Injury
Phase 2RecruitingThe University of Texas Health Science Center, Houston4002025-01-242025-05-14
PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease
Omeprazole 40 mg IV, pantoprazole 40 mg iv - Morbidity
Phase 2RecruitingUniversidad Autonoma de Nuevo Leon602024-10-202026-06-12
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
Protonix (Pantoprazole) 40 mg q 12 hrs for 2 days, Protonix (pantoprazole) 40 mg q 24 hrs for 2 days - Acute Kidney Injury
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center, Houston1002024-09-072026-02-19
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Tegoprazan, Pantoprazole - Gastroesophageal Reflux Disease
Phase 4RecruitingCarnot Laboratories1282024-07-302025-07-23
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
BMS-986470, Placebo, Famotidine - Anemia, Sickle Cell, Healthy Volunteers
Phase 1 / Phase 2RecruitingBristol-Myers Squibb2242024-07-172026-08-18
The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer
Coenzyme Q10, Oxaliplatin, 5-Fluorouracil (5-FU) - Colorectal Cancer
Phase 1Recruitingtoqa saad mohammed mohammed222024-06-012025-03-04
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Pantoprazole, Famotidine - Acute Kidney Injury
Phase 2CompletedThe University of Texas Health Science Center, Houston1002024-01-102026-03-10
Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter Pylori
Vonoprazan, Amoxicillin and Levofloxacin, Pantoprazole 40mg, Amoxicillin and Levofloxacin - Helicobacter Pylori Infection
Phase 3CompletedAin Shams University3202023-10-122024-05-16
Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding
Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage
Phase 4Not yet recruitingWest China Hospital6722023-10-012023-09-28
Baduanjin Program Effect on Geriatric Functional Dyspepsia
baduinjuin activities, pantoprazole - Functional Dyspepsia
Not applicableUnknownCairo University402023-07-202023-06-23
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Vonoprazan-based dual eradication therapy for two weeks, amoxicillin, Pantoprazole - Acute Coronary Syndrome, Helicobacter Pylori Infection
Phase 4RecruitingQilu Hospital of Shandong University26002023-04-122025-09-16
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
pantoprazole, Placebo - Postoperative Nausea and Vomiting
Phase 2RecruitingUnited States Naval Medical Center, Portsmouth1322022-08-262025-05-21
Efficacy and Safety of Thread Embedding Acupuncture in Treating Gastroesophageal Reflux Disease
Thread embedding acupuncture, Pantoprazole 40mg - Gastroesophageal Reflux
Not applicableCompletedUniversity of Medicine and Pharmacy at Ho Chi Minh City662022-05-042022-07-28
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Placebo, Pantoprazole - Pancreatic Cancer, Pancreas Cancer
Phase 2TerminatedWashington University School of Medicine562022-04-212025-05-06

Showing 20 of 183. Sign in to see all of them.

Conditions studied

Gastroesophageal Reflux (40)  ·  Gastrointestinal Hemorrhage (8)  ·  Peptic Ulcer (8)  ·  Dyspepsia (5)  ·  Heartburn (5)  ·  Non-Erosive Reflux Disease (5)  ·  Peptic Ulcer Hemorrhage (5)  ·  Acute Kidney Injury (4)  ·  Ulcer (4)  ·  Acute Coronary Syndrome (3)  ·  Coronary Artery Disease (3)  ·  Esophagitis (3)  ·  Hemorrhage (3)  ·  Neoplasms (3)  ·  Pneumonia (3)

Sponsors

Boehringer Ingelheim (13)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (9)  ·  Kaohsiung Veterans General Hospital. (8)  ·  Takeda (8)  ·  Nycomed (5)  ·  AstraZeneca (3)  ·  McMaster University (3)  ·  National Taiwan University Hospital (3)  ·  Seoul National University Hospital (3)  ·  The University of Texas Health Science Center, Houston (3)  ·  Alexandria University (2)  ·  Asan Medical Center (2)  ·  Assiut University (2)  ·  Bristol-Myers Squibb (2)  ·  Children's Mercy Hospital Kansas City (2)

Countries

United States (45)  ·  Canada (18)  ·  Germany (18)  ·  South Korea (14)  ·  Taiwan (13)  ·  Italy (10)  ·  India (8)  ·  Netherlands (8)  ·  Australia (7)  ·  Belgium (7)  ·  China (7)  ·  Denmark (7)  ·  Poland (7)  ·  Switzerland (7)  ·  United Kingdom (7)

Top investigators

Ping-I Hsu, Bachelor (3)  ·  Yafen Liang, MD (3)  ·  Dr. Thomas D. Bethke, MD, MBA (2)  ·  Feng-Woei Tsay, Bachelor (2)  ·  Lars Arendt-Nielsen, Dr.Sci.Med. (2)  ·  Lifen Yu, MD, Ph.D (2)  ·  Mangesh Kulkarni, M.D (2)  ·  Mattijs E Numans, MD, PhD (2)  ·  Steven Herrmann, M.D.; Ph.D (2)  ·  Tim Vanuytsel, MD PhD (2)

Results publications

PMID 26304646, PMID 29369450, PMID 29723634, PMID 32088712, PMID 19086953, PMID 19150702, PMID 19301059, PMID 20132153, PMID 20456300, PMID 20844485, PMID 20858862, PMID 21188333, PMID 21521834, PMID 21569313, PMID 21740077, PMID 21762268, PMID 22281110, PMID 22463973, PMID 22571284, PMID 23151395, PMID 23630016, PMID 23856153, PMID 24083350, PMID 24782414, PMID 25070099, PMID 25200403, PMID 25704601, PMID 26241775, PMID 26937932, PMID 27004241, PMID 27029553, PMID 27087519, PMID 27093939, PMID 27144617, PMID 27460100, PMID 27687850, PMID 27707777, PMID 27709460, PMID 27920416, PMID 28018669, PMID 28266875, PMID 28395507, PMID 28533916, PMID 28624580, PMID 28754388, PMID 28807915, PMID 28844176, PMID 28844192, PMID 29082856, PMID 29132877

NIH funding

2004 (1), 2014 (1), 2023 (1), K23DK115827 (1)